Mereo BioPharma Group (MREO) Earnings Date & Reports

Mereo BioPharma Group PLC is a United Kingdom (U... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MREO is expected to report earnings to rise 35.50% to -2 cents per share on October 07

Mereo BioPharma Group MREO Stock Earnings Reports

Q2'25

Est.

$-0.03

Q1'25

Missed

by $0.03

Q4'24

Est.

$-0.01

Q3'24

Est.

$-0.02

Q2'24

Missed

by $0.01

The last earnings report on May 13 showed earnings per share of -1 cents, missing the estimate of 0 cents. With 36.82K shares outstanding, the current market capitalization sits at 364.11M.

View a ticker or compare two or three

Compare

MREO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MREO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Cavendish Place

Phone

+44 3330237300

Employees

Web

https://www.mereobiopharma.com